-
1.发明授权4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease 有权4-羟基-2-甲基-5-（丙-2-亚基）环己-3-烯醛用于预防和治疗认知，神经变性或神经元疾病公开(公告)号：US09284250B2
公开(公告)日：2016-03-15
申请号：US14758343
申请日：2013-12-17
Applicant: CESA ALLIANCE S.A.
Inventor： Reiner Van Tilborg
CPC classification number: C07C47/46 , A61K9/0095 , A61K31/11 , A61K47/44 , A61K49/0433 , A61K51/04 , C07C2601/16
Abstract: The present invention concerns a pharmaceutical compound having the Formula (1): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of a cognitive, neurodegenerative or neuronal disorder or disease such as the Alzheimer Disease, a pharmaceutical composition and a method of preparing a pharmaceutical composition.
Abstract translation: 本发明涉及用于预防或治疗认知，神经变性或神经元病症或疾病如阿尔茨海默病的药学上可接受的式（1）化合物或其药学上可接受的盐，药物组合物和方法 制备药物组合物。
-
公开(公告)号：US09611205B2
公开(公告)日：2017-04-04
申请号：US15069118
申请日：2016-03-14
Applicant: Cesa Alliance S.A.
Inventor： Reiner Van Tilborg
CPC classification number: C07C47/46 , A61K9/0095 , A61K31/11 , A61K47/44 , A61K49/0433 , A61K51/04 , C07C2601/16
Abstract: Contemplated compounds, compositions, and methods are presented for use in the treatment, or prevention, of a cognitive, neurodegenerative or neuronal disorder or disease, such as Alzheimer's disease.
-
公开(公告)号：US20160194266A1
公开(公告)日：2016-07-07
申请号：US15069118
申请日：2016-03-14
Applicant: Cesa Alliance S.A.
Inventor： Reiner Van Tilborg
CPC classification number: C07C47/46 , A61K9/0095 , A61K31/11 , A61K47/44 , A61K49/0433 , A61K51/04 , C07C2601/16
Abstract: Contemplated compounds, compositions, and methods are presented for use in the treatment, or prevention, of a cognitive, neurodegenerative or neuronal disorder or disease, such as Alzheimer's disease.
Abstract translation: 提出了考虑的化合物，组合物和方法用于治疗或预防认知，神经变性或神经元病症或疾病如阿尔茨海默病。
-
-
Search Results
3
records
(took 0.016 seconds)
